1. Reading CM. Down's syndrome: nutritional intervention. Nutr Health 1984;3:91-111 [review].
2. Teksen F, Sayli BS, Aydin A, et al. Antioxidative metabolism in Down syndrome. Biol Trace Elem Res 1998;63:123-7.
3. Luke A, Sutton M, Schoeller DA, Roizen NJ. Nutrient intake and obesity in prepubescent children with Down syndrome. J Am Diet Assoc 1996;96:1262-7.
4. Chad K, Jobling A, Frail H. Metabolic rate: a factor in developing obesity in children with Down syndrome? Am J Ment Retard 1990;95:228-35.
5. Abalan F, Jouan A, Weerts MT, et al. A study of digestive absorption in four cases of Down's syndrome. Down's syndrome, malnutrition, malabsorption, and Alzheimer's disease. Med Hypotheses 1990;31:35-8.
6. Reading CM. Down's syndrome: nutritional intervention. Nutr Health 1984;3:91-111 [review].
7. Storm W. Prevalence and diagnostic significance of gliadin antibodies in children with Down syndrome. Eur J Pediatr 1990;149:833-4.
8. Zubillaga P, Vitoria JC, Arrieta A, et al. Down's syndrome and celiac disease. J Pediatr Gastroenterol Nutr 1993;16:168-71.
9. Castro M, Crino A, Papadatou B, et al. Down's syndrome and celiac disease: the prevalence of high IgA-antigliadin antibodies and HLA-DR and DQ antigens in trisomy 21. J Pediatr Gastroenterol Nutr 1993;16:265-8.
10. Jansson U, Johansson C. Down syndrome and celiac disease. J Pediatr Gastroenterol Nutr 1995;21:443-5.
11. George EK, Mearin ML, Bouquet J, et al. High frequency of celiac disease in Down syndrome. J Pediatr 1996;128:555-7.
12. George EK, Mearin ML, Bouquet J, et al. Screening for coeliac disease in Dutch children with associated diseases. Acta Paediatr Suppl 1996;412:52-3.
13. Bonamico M, Rasore-Quartino A, Mariani P, et al. Down syndrome and coeliac disease: usefulness of antigliadin and antiendomysium antibodies. Acta Paediatr 1996;85:1503-5.
14. Gale L, Wimalaratna H, Brotodiharjo A, Duggan JM. Down's syndrome is strongly associated with coeliac disease. Gut 1997;40:492-6.
15. Carlsson A, Axelsson I, Borulf S, et al. Prevalence of IgA-antigliadin antibodies and IgA-antiendomysium antibodies related to celiac disease in children with Down syndrome. Pediatrics 1998;101:272-5.
16. Hansson T, Anneren G, Sjoberg O, et al. Celiac disease in relation to immunologic serum markers, trace elements, and HLA-DR and DQ antigens in Swedish children with Down syndrome. J Pediatr Gastroenterol Nutr 1999;29:286-92.
17. Pueschel SM, Romano C, Failla P, et al. A prevalence study of celiac disease in persons with Down syndrome residing in the United States of America. Acta Paediatr 1999;88:953-6.
18. Castro M, Crino A, Papadatou B, et al. Down's syndrome and celiac disease: the prevalence of high IgA-antigliadin antibodies and HLA-DR and DQ antigens in trisomy 21. J Pediatr Gastroenterol Nutr 1993;16:265-8.
19. Lazzari R, Collina A, Arena G, et al. Celiac disease in children with Down's syndrome. Pediatr Med Chir 1994;16:467-70 [in Italian].
20. Bonamico M, Rasore-Quartino A, Mariani P, et al. Down syndrome and coeliac disease: usefulness of antigliadin and antiendomysium antibodies. Acta Paediatr 1996;85:1503-5.
21. Carlsson A, Axelsson I, Borulf S, et al. Prevalence of IgA-antigliadin antibodies and IgA-antiendomysium antibodies related to celiac disease in children with Down syndrome. Pediatrics 1998;101:272-5.
22. Kanavin O, Scott H, Fausa O, et al. Immunological studies of patients with Down's syndrome. Measurements of autoantibodies and serum antibodies to dietary antigens in relation to zinc levels. Acta Med Scand 1988;224:473-7.
23. Sharav T, Bowman T. Dietary practices, physical activity, and body-mass index in a selected population of Down syndrome children and their siblings. Clin Pediatr 1992;31:341-4.
24. Fujiura GT, Fitzsimons N, Marks B, Chicoine B. Predictors of BMI among adults with Down syndrome: the social context of health promotion. Res Dev Disabil 1997;18:261-74.
25. Angelopoulou N, Matziari C, Tsimaras V, et al. Bone mineral density and muscle strength in young men with mental retardation (with and without Down syndrome). Calcif Tissue Int 2000;66:176-80.
26. Eberhard Y, Eterradossi J, Therminarias A. Biochemical changes and catecholamine responses in Down's syndrome adolescents in relation to incremental maximal exercise. J Ment Defic Res 1991;35:140-6.
27. Pitetti KH, Climstein M, Campbell KD, et al. The cardiovascular capacities of adults with Down syndrome: a comparative study. Med Sci Sports Exerc 1992;24:13-9.
28. Millar AL, Fernhall B, Burkett LN. Effects of aerobic training in adolescents with Down syndrome. Med Sci Sports Exerc 1993;25:270-4.
29. Millar AL, Fernhall B, Burkett LN. Effects of aerobic training in adolescents with Down syndrome. Med Sci Sports Exerc 1993;25:270-4.
30. Peran S, Gil JL, Ruiz F, Fernandez-Pastor V. Development of physical response after athletics training in adolescents with Down's syndrome. Scand J Med Sci Sports 1997;7:283-8.
31. Pueschel SM, Werner JC. Mitral valve prolapse in persons with Down syndrome. Res Dev Disabil 1994;15:91-7.
32. Crawford JG. Alzheimer's disease risk factors as related to cerebral blood flow. Med Hypotheses 1996;46:367-77 [review].